HOW CAR-T CELLS ARE ENGINEERED TO FIGHT CANCER

A chimeric antigen receptor (CAR) sprouts from the surface of a genetically reengineered white blood cell.

The receptor is a manufactured protein, and designed by molecular biologists to seek out and interact with specific antigens appearing on cancer cells.

Now empowered with CAR, these killer T-cells are infused into the patient to attack and kill cancer cells.

Cancer immunotherapy is a rapidly growing field that is showing incredible promise.

Numerous clinical trials are underway.

Animation credit: hybridmedical